Search results for "Highlights"
COVID-19 guidance released for managing IBD patients, endoscopic procedures
The American Gastroenterological Association released new guidance for clinicians caring for patients with inflammatory bowel disease (IBD) and those performing endoscopic procedures, and two recent studies looked at GI symptoms in patients with COVID-19.
https://gastroenterology.acponline.org/archives/2020/04/24/1.htm
24 Apr 2020
Novel therapy may be effective treatment for H. pylori infection, industry-funded trial finds
About 84% of participants randomly assigned to receive rifabutin in addition to amoxicillin and omeprazole achieved Helicobacter pylori eradication, compared to 58% of those who received amoxicillin and omeprazole alone.
https://gastroenterology.acponline.org/archives/2020/05/22/2.htm
22 May 2020
Risk and severity of NAFLD differ in men and women
Women have a significantly lower risk of developing nonalcoholic fatty liver disease (NAFLD) but a higher risk of developing advanced fibrosis from NAFLD, according to a systematic review and meta-analysis.
https://gastroenterology.acponline.org/archives/2020/05/22/3.htm
22 May 2020
Guidance issued for comanagement of COVID-19 GI, liver manifestations
Two meta-analyses, one of them from the American Gastroenterological Association (AGA), found that GI symptoms and liver abnormalities are not uncommon in patients with COVID-19. The AGA issued a series of best practice statements based on its findings.
https://gastroenterology.acponline.org/archives/2020/05/22/1.htm
22 May 2020
Inflammatory bowel disease associated with higher risk for dementia
Patients with inflammatory bowel disease were diagnosed with dementia an average of seven years earlier than matched controls in a Taiwanese study.
https://gastroenterology.acponline.org/archives/2020/06/26/2.htm
26 Jun 2020
Steroids may not be needed with anti-TNF induction in Crohn's disease
Rates of clinical remission and clinical response were 32.0% and 42.7%, respectively, in Crohn's disease patients receiving therapy with both corticosteroids and anti-tumor necrosis factor (TNF) agents and 35.5% and 46.8% in those receiving only anti-TNF agents, a systematic review and meta-analysis found.
https://gastroenterology.acponline.org/archives/2020/06/26/3.htm
26 Jun 2020
New guidelines support probiotics for C. difficile prevention, but few other uses
The American Gastroenterological Association recommended that probiotics be used to treat patients with Clostridioides difficile infection, Crohn's disease, ulcerative colitis, or irritable bowel syndrome only in the context of a clinical trial.
https://gastroenterology.acponline.org/archives/2020/06/26/1.htm
26 Jun 2020
Cannabis, cannabinoids didn't improve remission or inflammatory markers in IBD
A meta-analysis of inflammatory bowel disease (IBD) studies did find improvements in patient-reported symptoms and quality of life associated with cannabis and cannabinoids.
https://gastroenterology.acponline.org/archives/2020/07/24/3.htm
24 Jul 2020
Liver cancer diagnosis delayed in almost half of veterans with cirrhosis
Failure to follow guidelines, diagnostic imaging without alpha-fetoprotein measurement, and diagnosis from an incidental finding were all associated with a delay of more than 60 days between a red flag for hepatocellular carcinoma and a diagnosis, a retrospective study found.
https://gastroenterology.acponline.org/archives/2020/07/24/2.htm
24 Jul 2020
ACIP updates hepatitis A vaccination recommendations
The Advisory Committee on Immunization Practices (ACIP) changed its recommendations regarding vaccination of patients with chronic liver disease, pregnant women, and those treated with blood products for clotting disorders, among other revisions.
https://gastroenterology.acponline.org/archives/2020/07/24/1.htm
24 Jul 2020